UK Markets closed

NNIT A/S (NNIT.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
105.80-1.80 (-1.67%)
At close: 04:59PM CET
Full screen
Previous close107.60
Open106.80
Bid106.00 x 0
Ask106.20 x 0
Day's range104.00 - 107.00
52-week range101.00 - 145.60
Volume22,128
Avg. volume19,328
Market cap2.613B
Beta (5Y monthly)1.40
PE ratio (TTM)34.80
EPS (TTM)3.04
Earnings date27 Jan 2022 - 31 Jan 2022
Forward dividend & yield3.00 (2.58%)
Ex-dividend date11 Mar 2021
1y target est142.50
  • Globe Newswire

    NNIT A/S: 09/2021 Financial report for the first nine months of 2021

    Company announcement 09/2021: Financial report for the first nine months of 2021 Revenue increase of 6.1% and an operating profit margin before special items of 3.0% related to Q3 2021 Performance highlights for Q3 2021 Revenue increased to DKK 698m, up 6.1% (-1.5% organic) from Q3 2020, driven by: Life Sciences (excluding Novo Nordisk Group) grew to DKK 246m, up 36% (13% organic). The increase was related to the continued significant growth of the Life Sciences International business, where rev

  • Globe Newswire

    NNIT A/S: 08/2021 Financial report for the first six months of 2021

    Company announcement 08/2021: Financial report for the first six months of 2021 Revenue increase of 1.3% and an operating profit margin before special items of 5.1% Performance highlights for the second quarter of 2021 New CEO Pär Fors took office as CEO of NNIT on June 14, 2021Revenue increased to DKK 710m, up 1.3% (-1.8% organic) from Q2 2020, driven by: Life Sciences (excluding Novo Nordisk Group) grew to DKK 234m, up 35% (22% organic). The increase was related to the continued significant gr

  • Globe Newswire

    NNIT A/S: 07/2021 The NNIT Group renews infrastructure management agreement with Novo Nordisk and adjusts the company’s financial outlook

    The NNIT Group renews infrastructure management agreement with Novo Nordisk and adjusts the company’s financial outlook The NNIT Group, a leading provider of IT services and consultancy has entered into an agreement with Novo Nordisk to renew the existing infrastructure agreement which was to expire ultimo 2022. The renewed agreement secures the substantial business with Novo Nordisk for another five years and will cover the operations of Novo Nordisk’s global IT infrastructure, including new se